Airoli, India

Vaibhav Panditrao Deshmukh

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Cipla Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vaibhav Panditrao Deshmukh. Retrieved from https://idiyas.com/inventor/vaibhav-panditrao-deshmukh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Vaibhav Panditrao Deshmukh: Innovator in Pharmaceutical Formulations

Introduction

Vaibhav Panditrao Deshmukh is a notable inventor based in Airoli, India. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of soft gelatin capsules.

Latest Patents

Deshmukh holds a patent for a pharmaceutical formulation that includes soft gelatin capsules comprising a suspension composition of nintedanib or a pharmaceutically acceptable salt thereof in medium chain triglycerides. The carrier system for this formulation consists of solubilizers, phospholipids, thickeners, and mixtures thereof. This innovation showcases his expertise in creating effective drug delivery systems.

Career Highlights

Vaibhav Deshmukh is currently employed at Cipla Limited, a leading global pharmaceutical company. His work at Cipla has allowed him to focus on innovative solutions that enhance patient care and treatment efficacy.

Collaborations

Some of his notable coworkers include Geena Malhotra and Dipak Narayan Date. Their collaboration has contributed to the advancement of pharmaceutical research and development within the company.

Conclusion

Vaibhav Panditrao Deshmukh is a distinguished inventor whose work in pharmaceutical formulations has the potential to impact the healthcare industry significantly. His innovative approach and dedication to improving drug delivery systems are commendable.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…